Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioFCF Payout RatioInventory AverageInvested Capital

Conmed (CNMD) Gross Margin (2016 - 2020)

Historic Gross Margin for Conmed (CNMD) over the last 11 years, with Q4 2020 value amounting to 53.6%.

  • Conmed's Gross Margin changed 0.0% to 53.6% in Q4 2020 from the same period last year, while for Dec 2020 it was 53.37%, marking a year-over-year decrease of 15700.0%. This contributed to the annual value of 54.59% for FY2025, which is 14900.0% down from last year.
  • Per Conmed's latest filing, its Gross Margin stood at 53.6% for Q4 2020, which was down 0.0% from 56.21% recorded in Q3 2020.
  • Conmed's Gross Margin's 5-year high stood at 56.21% during Q3 2020, with a 5-year trough of 45.59% in Q2 2020.
  • For the 5-year period, Conmed's Gross Margin averaged around 53.98%, with its median value being 54.43% (2018).
  • In the last 5 years, Conmed's Gross Margin skyrocketed by 32900bps in 2017 and then tumbled by -94700bps in 2020.
  • Quarter analysis of 5 years shows Conmed's Gross Margin stood at 52.41% in 2016, then increased by 6bps to 55.7% in 2017, then dropped by -2bps to 54.72% in 2018, then decreased by -2bps to 53.6% in 2019, then fell by 0bps to 53.6% in 2020.
  • Its last three reported values are 53.6% in Q4 2020, 56.21% for Q3 2020, and 45.59% during Q2 2020.